glp 1 with payment plan Medically Guided Weight Loss Membership — Real Results, Real Support No Insurance GLP-1 and GLP-1/GIP

As of June 2025, the FDA removed both semaglutide and tirzepatide from its drug shortage list, a move that limits when and how pharmacies can legally compound these medications

Rather than aiming for individuals to commit to complete abstinence, these medications may allow for meaningful reductions in alcohol consumption, decreasing both the intensity and frequency of heavy drinking episodes

In fact, 29% of adults who are not currently using a GLP-1 say they would consider doing so if it were more accessible and cost-effective

Bengsch B, Seigel B, Flecken T, Wolanski J, Blum HE, Thimme R

Investigating cardiovascular health outcomes is critical, as weight loss may reduce long-term risks of hypertension, atherosclerosis, and insulin resistance